COVID-19 Patient Management
Value of Electrical Cardiometry™
Value of Electrical Cardiometry™
SARS-CoV-2 broke out in December 2019, and it spreads from Wuhan, Hubei Province, to all over China and many other countries in the world, and since COVID-19 emerged, data was needed on the clinical characteristics of the affected patients.
Achieving circulatory stability is sometimes a real challenge in critical patients due to the complex hemodynamics (blood flow, vascular resistance and fluid status) of these patients, and the difficulty to use invasive lines.
The clinical assessment of systemic blood flow (SBF) by indirect parameters, such as “blood pressure, capillary refill time, heart rate, urine output, and CVP” is inaccurate. Information on cardiac output, systemic vascular resistance and end organ perfusion should be obtained to detect inadequate tissue perfusion and oxygenation at early stage.
When deciding to initiate treatment? Should every patient with hypotension be treated the same way? Which therapy is the best for each patient, inotropes, vasopressors or fluid?
The hemodynamic response to the initiated treatment should be regularly assessed and the dose adjusted accordingly, as changes in cardiovascular function can occur quickly.